• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    FDA Grants Orphan Drug To Can-Fite`s Namodenoson

    GLOBENEWSWIRE

    Can-Fite Seeks FDA Orphan Drug Status For Namodenoson In Pancreatic Cancer

    GLOBENEWSWIRE

    Can-Fite to Share its Rare Genetic Disease Lowe Syndrome Novel Treatment

    BUSINESSWIRE

    Can-Fite to Share with Investors Oncology and Rare Genetic Disease Developments

    BUSINESSWIRE

    Can-Fite Enters Rare Disease Field Based on findings of a Fondazione Telethon

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.